Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Krumme, B.
Right arrow Articles by Mann, J. F. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krumme, B.
Right arrow Articles by Mann, J. F. E.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nephrol Dial Transplant (2001) 16: 2124-2127
© 2001 European Renal Association-European Dialysis and Transplant Association

Editorial Comments

Atherosclerotic renal artery stenosis in 2001—are we less confused than before?

Bernd Krumme1, and Johannes F. E. Mann2

1Deutsche Klinik für Diagnostik, Fachbereich Nephrologie, Wiesbaden, Germany and 2VI Medizinische Abteilung, Städtisches Klinikum Schwabing, München, Germany

Introduction

Atherosclerotic renal artery stenosis (ARAS) may cause ischaemic nephropathy and renovascular hypertension. Nephropathy and hypertension may occur separately or together [1]. In clinical decision-making about screening for and therapy of ARAS, we have to balance the chance of improving renal function and blood pressure with the risks of interventional procedures. Recent randomized studies comparing percutaneous transluminal angioplasty (PTA) with medical treatment of hypertension in patients with ARAS suggested no real short-term benefit of PTA [2–4]. These new results may be an incentive to abandon invasive strategies in many centres. In those studies [2–4] some subgroups of patients benefited from intervention. Therefore, the mystery of identifying these subgroups by clinical clues in combination with non-invasive imaging procedures has to be solved. The rapid progress in this field necessitates an update.

Diagnosis of atherosclerotic renal artery stenosis

Screening
The prevalence of ARAS is low in a non-selected population of . . . [Full Text of this Article]

Non-invasive testing
Therapy

Conclusion

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Eur Heart JHome page
R. de Silva, N. P. Nikitin, S. Bhandari, A. Nicholson, A. L. Clark, and J. G.F. Cleland
Atherosclerotic renovascular disease in chronic heart failure: should we intervene?
Eur. Heart J., August 2, 2005; 26(16): 1596 - 1605.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
D. Weber-Mzell, P. Kotanko, M. Schumacher, W. Klein, and F. Skrabal
Coronary anatomy predicts presence or absence of renal artery stenosis. A prospective study in patients undergoing cardiac catheterization for suspected coronary artery disease
Eur. Heart J., November 1, 2002; 23(21): 1684 - 1691.
[Abstract] [Full Text] [PDF]